Numeric Investors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$4.46M Buy
+179,700
New +$4.96M 0.03% 452
2017
Q2
Sell
-9,400
Closed -$234K 1018
2017
Q1
$234K Sell
9,400
-19,300
-67% -$469K ﹤0.01% 940
2016
Q4
$621K Sell
28,700
-52,800
-65% -$1.15M 0.01% 769
2016
Q3
$1.94M Buy
+81,500
New +$1.94M 0.02% 478
2015
Q4
Sell
-455,900
Closed -$7.48M 988
2015
Q3
$7.48M Buy
455,900
+319,600
+234% +$5.46M 0.09% 194
2015
Q2
$2.41M Sell
136,300
-1,007,400
-88% -$18M 0.03% 360
2015
Q1
$20.3M Buy
1,143,700
+906,200
+382% +$14.3M 0.25% 96
2014
Q4
$3.15M Buy
+237,500
New +$3.04M 0.04% 296
2014
Q3
Sell
-30,300
Closed -$387K 820
2014
Q2
$387K Sell
30,300
-18,100
-37% -$235K 0.01% 617
2014
Q1
$654K Buy
48,400
+30,400
+169% +$399K 0.01% 528
2013
Q4
$216K Buy
+18,000
New +$213K ﹤0.01% 727

Other funds holding BSX

Numeric Investors's BSX Position: Q4 2017 in Review

Numeric Investors opened a new position in Boston Scientific (BSX) in Q4 2017: 179,700 shares worth $4.46M. The stake represents 0.03% of the portfolio and ranks #452 among its holdings. This is a return to the name: Numeric Investors previously reported a position in BSX as recently as Q1 2017.

Numeric Investors first reported a position in BSX in Q4 2013 and has held it in 11 quarters since. The position peaked at $20.3M in Q1 2015. 632 funds tracked by Wall St. Rank hold BSX as of Q4 2017.

  • Numeric Investors held 179,700 shares of Boston Scientific worth $4.46M as of Q4 2017.
  • Boston Scientific was a new Numeric Investors position in Q4 2017.
  • Boston Scientific made up 0.03% of Numeric Investors's portfolio in Q4 2017, its #452 holding.
  • Numeric Investors first reported a position in Boston Scientific in Q4 2013 and has held it in 11 quarters since.
  • Numeric Investors's Boston Scientific position peaked at $20.3M in Q1 2015.
  • 632 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.